100%/100% at all stages for Ovarian cancer is excellent. The nearest competitions have no where near close to this result, and yet market caps are in the $1b US range.
The details of the size of the population who could benefit is eye opening. A survivor of breast cancer - knowing that the risk of relapse is very real, a blood test every 3-6 months to keep an eye on cancer rearing its head again would be not only buying a head start on any relapse but buying peace of mind. Catching cancer early = a chance of survival
Ann: BARD1 Investor Presentation, page-5
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
-0.015(3.13%) |
Mkt cap ! $51.85M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.0¢ | 46.0¢ | $95.71K | 205.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.20pm 11/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |